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Abstract
Sophisticated genetic tools to modify essential biological processes at the molecular level are pivotal in elucidating the
molecular pathogenesis of Clostridium difficile, a major cause of healthcare associated disease. Here we have developed an
efficient procedure for making precise alterations to the C. difficile genome by pyrE-based allelic exchange. The robustness
and reliability of the method was demonstrated through the creation of in-frame deletions in three genes (spo0A, cwp84,
and mtlD) in the non-epidemic strain 630Derm and two genes (spo0A and cwp84) in the epidemic PCR Ribotype 027 strain,
R20291. The system is reliant on the initial creation of a pyrE deletion mutant, using Allele Coupled Exchange (ACE), that is
auxotrophic for uracil and resistant to fluoroorotic acid (FOA). This enables the subsequent modification of target genes by
allelic exchange using a heterologous pyrE allele from Clostridium sporogenes as a counter-/negative-selection marker in the
presence of FOA. Following modification of the target gene, the strain created is rapidly returned to uracil prototrophy
using ACE, allowing mutant phenotypes to be characterised in a PyrE proficient background. Crucially, wild-type copies of
the inactivated gene may be introduced into the genome using ACE concomitant with correction of the pyrE allele. This
allows complementation studies to be undertaken at an appropriate gene dosage, as opposed to the use of multicopy
autonomous plasmids. The rapidity of the ‘correction’ method (5–7 days) makes pyrE2 strains attractive hosts for
mutagenesis studies.
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Introduction
Clostridium difficile is the major cause of nosocomial diarrhoea
and a major burden to healthcare services worldwide. The
organism is resistant to various broad-spectrum antibiotics and
capitalises on the disruption of the normal intestinal flora to cause
disease symptoms ranging from asymptomatic carriage to a
fulminant, relapsing and potentially fatal colitis [1,2]. Sophisticat-
ed genetic tools to modify essential biological processes at the
molecular level are pivotal in enabling the systematic study of the
basis of colonization, virulence and pathogenesis of C. difficile. The
requisite systems ideally need to be able to both make precise, in
situ alterations to existing alleles, as well as introduce entirely new
alleles to progress hypothesis driven research. The former include
the generation of in-frame deletions and the introduction or
correction of single or multiple nucleotide substitutions, deletions
and insertions. The latter is required both to add entirely new, or
altered alleles or provide the facility for the complementation of
distal mutant alleles at chromosomal gene dosage.
For many years the required level of sophistication has been
unavailable. Thus, directed mutants could only be made using
insertional mutagens, reliant either on replication deficient [3] or
defective [4,5] plasmids, or on the deployment of the ClosTron
and group II intron re-targeting [6,7]. Recently, however, the
cytosine deaminase gene (codA) of Escherichia coli was developed as a
negative/counter selection marker for C. difficile, which enabled
precise manipulation of the C. difficile chromosome for the first
time [8]. In parallel, a second method (Allele-Coupled Exchange,
ACE) has been formulated that allows the rapid insertion of
heterologous DNA, of any size or complexity, into the genome [9].
Whilst a number of different genetic loci may be used to insert
heterologous DNA via ACE, one exemplification of the method
exploits the native pyrE gene, bringing about its inactivation by
replacement of the wild type allele with a mutant allele lacking the
codons from both the 59 and 39 end of the structural gene. The
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pyrE gene encodes orotate phosphoribosyltransferase
[E.C.2.4.2.10]), which is an enzyme involved in de novo pyrimidine
biosynthesis. It may be used as a positive/negative selection
marker as it is essential in the absence of exogenous pyrimidines
and it also renders 5-fluoro-orotate (FOA) toxic to cells. Toxicity
occurs via a series of steps which result in misincorporation of
fluorinated nucleotides into DNA and RNA and hence, cause cell
death.
Mutant strains defective in pyrE created using ACE become
auxotrophs requiring exogenous uracil to grow. They also lends
themselves to the use of a functional pyrE allele as a negative/
counter selection marker in a similar way to codA [8].The
functionally equivalent gene, URA5, and URA3 (encoding
orotidine-phosphate decarboxylase) have been widely used as
negative selection markers in Saccharomyces cerevisiae [10]. Indeed,
this approach has allowed homologous gene replacement in a
range of different microbes [11–14], including most recently
Clostridium thermocellum [15] using the organisms own pyrF gene
(equivalent to URA3) in a specifically created DpyrF mutant. Not
unexpectedly, the DpyrF strain created required the addition of
exogenous uracil to achieve equivalent cell density to the wild type
in the rich media employed. With supplementation, whilst growth
was slightly delayed, the eventual the growth rate was comparable
to wildtype [15].
In this study, we have developed a procedure for the generation
of allelic exchange mutants in pyrE mutants of two different strains
of C. difficile (strain 630Derm and a BI/NAP1/PCR-Ribotype 027
strain, R20291) using a heterologous pyrE allele from Clostridium
sporogenes as a negative/counter-selection marker. Use of a
heterologous pyrE allele avoids homologous recombination with
the native pyrE locus of C. difficile. The system has been used to
make in-frame deletions in three different genes, spo0A (the master
regulator of sporulation), cwp84 (which encodes a cysteine
protease) and mtlD (which encodes mannitol-1-phosphate 5-
dehydrogenase). Crucially, having created these mutants, a specific
ACE-vector is used to rapidly (within 5–7 days) restore the
chromosomal pyrE allele to wild-type, allowing the specific in-
frame deletion mutant to be characterised in a clean, wild-type
background. Moreover, variants of the same vector may be used to
deliver the wild-type allele of the deleted gene, either under the
control of its native promoter or the strong fdx promoter, into the
genome. The former allows complementation studies to be
performed at an appropriate gene dosage, while the latter
potentially allows the assessment of the effect of overexpressing
the gene.
Results
Construction of a pyrE2 mutant of R20291
The pyrE2 mutant of strain 630Derm was previously made using
Allele-Coupled Exchange (ACE) and the purpose built, replication
defective vector pMTL-JH18::lambda6.5 [9]. It is based on the
replicon of plasmid pCB102 [16], previously shown to be the least
effective (most unstable in terms of segregation into daughter cells)
in strain 630Derm of the four replicons available in the
pMTL80000 modular vector series [17]. In strain R20291,
however, the plasmid pBP1 replicon is the most defective, ie.,
plasmids that use this replication region are more rapidly lost in
the absence of antibiotic selection [18]. Accordingly, pMTL-YN18
was constructed in order to generate a pyrE mutant of C. difficile
R20291 (Figure 1). pMTL-YN18 is equivalent to the pMTL-
JH18::lambda6.5 vector used to construct a DpyrE mutant in C.
difficile 630Derm, except the pCB102 replicon is substituted with
that of pBP1 and the 6.5 kb fragment of phage lambda DNA is
absent. It carries two asymmetric homology arms that flank a lacZ’
multiple cloning site (MCS) region. The shorter, 300 bp left-hand
homology arm (LHA) is composed of a variant pyrE allele that
lacks 50 nucleotides from the 59-end of the gene and is devoid of
235 bp from the 39-end of the gene. The larger 1200 bp right-
hand homology arm (RHA) encompasses the region residing
immediately downstream of the pyrE gene in the C. difficile genome.
Plasmid pMTL-YN18 was used to generate a pyrE mutant of C.
difficile R20291. Five independent fluoroorotic acid (FOA) resistant
colonies were chosen and shown to be pyrE deletion mutants.
Thus, they all required exogenous uracil for growth on minimal
media, were no longer thiamphenicol resistant, consistent with
plasmid loss, and generated a PCR fragment of the expected size
(623 bp) using primers that flanked the pyrE locus (Supporting
Information File S1). Nucleotide sequence of the 623 bp fragment
generated confirmed the presence of the expected deletion.
Restoration of pyrE+ phenotype in 630Derm and R20291
With pyrE mutants of both C. difficile 630Derm and R20291, it
was desirable to demonstrate that they could be converted back to
uracil prototrophy, through restoration of the pyrE locus to wild-
type. Accordingly, ACE plasmids pMTL-YN1 and pMTL-YN2
were constructed to correct the pyrE mutations in C. difficile
630Derm and R20291, respectively (Figure 2). These plasmids were
Figure 1. Plasmid pMTL-YN18. The ACE vector pMTL-YN18 is
designed to create a deletion mutant specifically in the C. difficile strain
R20191. Plasmid components are: CatP, the catP gene of Clostridium
perfringens conferring thiamphenicol resistance; ColE1, the replication
region of the E.coli plasmid ColE1; TraJ, transfer function of the RP4 oriT
region; RepA and Orf2, the replication region of the Clostridium
botulinum plasmid pBP1; LHA, left-hand homology arm encompassing a
300 bp internal fragment of the R20291 pyrE gene lacking 50
nucleotides from the 59-end, and 235 bp from the 39-end; RHA, right-
hand homology arm comprising encompassing the 1200 bp region of
DNA immediately downstream of pyrE, and; lacZ’, gene encoding the
alpha fragment of the E.coli b-galactosidase (and containing a multiple
cloning site region derived from plasmid pMTL20 [19]).
doi:10.1371/journal.pone.0056051.g001
Allelic Exchange in C. difficile Using PyrE
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e56051
broadly equivalent to pMTL-JH14, used to correct a similar pyrE
mutation in C. acetobutylicum [9], with a pyrE allele that lacked the
first 50 nucleotides of the open-reading-frame forming the short
300 bp LHA. Crucially, they differed from pMTL-JH14 in that
they did not carry the lacZ’ region present in this plasmid between
the LHA and RHA. As a consequence, the strains generated using
them would be indistinguishable from the wild-type at the pyrE
locus. Both plasmids were conjugated into their respective pyrE
mutants from an E. coli CA434 donor and, following the procedure
outlined in MATERIALS AND METHODS, several dozen
colonies were obtained that were able to grow without uracil
supplementation. Six random colonies from each strain were
screened by PCR using primers which annealed to the chromo-
somal genes that reside up- and down-stream of the pyrE gene. In
all cases, the expected 2,058 bp band was generated, equivalent to
the wild-type control, whereas no band was generated when the
template DNA was derived from the pyrE mutant (Supporting
Information File S1). Nucleotide sequencing of the fragment
generated confirmed that the cells carried a wild type pyrE gene.
Formulation of the components of an Allelic Exchange
vector
Aside from the gene specific knock-out cassettes, the two most
important components of the desired allelic exchange vector are
the pyrE allele, to be used as the negative/counter-selection
marker, and the clostridial plasmid replicon. In the case of the pyrE
allele, it is desirable that the gene used is heterologous, to avoid
recombination at the native chromosomal pyrE locus of C. difficile.
Therefore, we selected the pyrE gene of Clostridium sporogenes, which
shares only 65% identity with its C. difficile equivalent. The pyrE
gene was cloned into pMTL83151 and the resultant plasmid
(pMTL-ME2, Figure 4) shown to be able to restore the C. difficile
pyrE mutants to prototrophy, ie., they were able to grow on
minimal media lacking uracil supplementation (data not shown).
The isolation of the initial, single cross-over plasmid integrants
required for the creation of allelic exchange mutants is facilitated
by the use of ‘pseudo-suicide’ vectors [8,18]. These are plasmids
carrying catP (encoding resistance to thiamphenicol) that are
sufficiently replication defective for there to be a significant growth
disadvantage in the presence of thiamphenciol compared to cells
in which the plasmid, together with catP, has integrated. Such
integrated clones grow faster, and produce larger colonies, on agar
media supplemented with thiamphenicol, because all of the
progeny carry a copy of catP. Cells carrying catP on a non-
integrated, defective autonomous plasmid, in contrast, grow slower
because in the presence of antibiotic they are limited by the rate at
which the plasmid is segregated amongst the daughter population.
Previously, the pCB102-based plasmid had been made more
defective in strain 630Derm by increasing the size of the final vector
through the insertion of 6.5 kb of DNA derived from phage
Figure 2. PyrE ACE correction vectors for C. difficile 630Derm (pMTL-YN1) and R20291 (pMTL-YN2). Both vectors carry identical
components between their FseI and SbfI restriction sites. These are: CatP, the catP gene of Clostridium perfringens conferring thiamphenicol
resistance; ColE1, the replication region of the E.coli plasmid ColE1, and; TraJ, transfer function of the RP4 oriT region. Plasmids pMTL-YN1C and pMTL-
YN2C have an additional segment of DNA inserted between the left-hand homology arm (LHA) and the right-hand homology arm (RHA) which
carries: a transcriptional terminator (T1) of the ferredoxin gene of Clostridium pasteurianum; a copy of the lacZ’ gene encoding the alpha fragment of
the E.coli b-galactosidase, and; a multiple cloning site (MCS) region derived from plasmid pMTL20 [19]. Plasmids pMTL-YN1X and pMTL-YN2X differ
from pMTL-YN1C and pMTL-YN2C, respectively, in that they carrying the promoter region (Pfdx) of the Clostridium sporogenes ferredoxin gene.
doi:10.1371/journal.pone.0056051.g002
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lambda [9]. Here we took a different strategy, and explored the
effect of introducing a frame-shift mutation into the 39-end of
putative repH gene of the pCB102 replication region. Accordingly,
the modular plasmid pMTL83251 was cleaved with NsiI, treated
with T4 polymerase and subjected to self-ligation, yielding
pMTL83*251. Nucleotide sequencing confirmed that the expected
modification had occurred, altering the sequence ATGCAT to
AT. The resulting deletion of 4 nucleotides (TGCA) causes a
frame-shift in the coding sequence, replacing the COOH-terminal
region of RepH (CIKYYARSFKKAHVKKSKKKK) with
LNIMGALKKLM. The effect on segregational stability was
tested by growing cells of 630Derm carrying either pMTL83251 or
pMTL83*251 in the absence of antibiotic selection and measuring
plasmid loss. The results are shown in Figure 3, and demonstrate
that the frame-shift has caused a significant reduction in the
segregational stability of the plasmid.
Accordingly, the NsiI site of plasmid pMTL-ME2 was similarly
frame-shifted, and the resulting plasmid was designated pMTL-
YN3 (Figure 4). For manipulations in R20291, the pCB102
replication region of pMTL-YN3 was simply replaced with that of
pBP1, by cleaving pMTL-YN3 with AscI and FseI and replacing
the excised fragment carrying the pCB102 replicon with the
equivalent fragment from the pBP1-based plasmid pMTL82251
[17]. The resulting plasmid was designated pMTL-YN4 (Figure 4).
Exemplification of the System to create spo0A mutants of
strains 630Derm and R20291
To test the system, we made in-frame deletions in the spo0A
gene of both C. difficile 630Derm and R20291 using plasmids
pMTL-YN3::630spo0A* and pMTL-YN4::R20291spo0A*, respec-
tively, as detailed in the allele exchange procedure outlined in
MATERIALS AND METHODS. After two (630Derm) and four
(R20291) passages of the transconjugants on BHIS selective media,
one of the six visibly larger colonies derived from 630Derm, and
four of the six visibly larger colonies derived from R20291, were
found to be pure single crossover mutants by PCR (data not
shown). Subsequently, single colonies were re-streaked onto
minimal medium supplemented with FOA and uracil to select
for cells in which the integrated plasmid had excised. The isolated
FOA resistant colonies (four in the case of 630Derm and twelve in
the case of R20291) were then screened by PCR using primers
spo0A-YN-F2 and spo0A-YN-R2 that anneal to the upstream and
the downstream sequence of spo0A, respectively. Of the four
630Derm colonies screened, one yielded the expected 1,845 bp
DNA fragment, indicative of an in-frame deletion (Supporting
Information File S1). The other colonies yielded a 2,331 bp DNA
fragment, consistent with the presence of a wild-type copy of the
gene. In the case of R20291, two of the twelve colonies screened
yielded the 1,845 bp DNA fragment indicative of an in-frame
deletion (Supporting Information File S1). Nucleotide sequencing
of the 1,845 bp DNA fragments confirmed that the expected
allelic exchange event had taken place in all three putative
mutants.
The sporulation minus phenotype of the mutants was confirmed
by assaying colony forming units (cfu) on BHIS supplemented with
0.1% [w/v] sodium taurocholate before and after heat shock
(65uC for 30 min), as previously described [20]. In each case, no
colonies were obtained after heat shock, whereas the wild type
controls gave counts of 1.286104 and 9.176104 cfu for CRG2548
(R20191DpyrE) and CRG2547 (630DermDpyrE), respectively.
Phase contrast microscopy confirmed that unlike the wild type
strains, phase-bright spores were absent in the mutant cultures.
Creation and in situ complementation of in-frame
deletion mutants of cwp84
To further test the system, we constructed mutants of the cwp84
gene of both 630Derm and R20291. Cwp84 is a cysteine protease
responsible for the post-translational cleavage of SlpA into the two
proteins High Molecular Weight (HMW) and Low Molecular
Weight (LMW) SlpA, which are the major components of the C.
difficile surface layer. ClosTron mutants of cwp84 have been made
elsewhere in C. difficile 630Derm [21,22], and in the one study [22]
complemented using an autonomous plasmid. cwp84 in-frame
deletion mutants were constructed following an identical proce-
dure to that used to isolate the spo0A mutants, using plasmids
pMTL-YN3::630cwp84* and pMTL-YN4::R20291cwp84*. One of
the three 630Derm FOA resistant colonies screened yielded a
1,218 bp PCR product, indicative of the desired in-frame deletion
(Supporting Information File S1). In the case of R20291, three of
four FOA resistant colonies screened yielded the 1,218 bp PCR
product, indicative of the desired in-frame deletion (Supporting
Information File S1). Nucleotide sequencing of the 1,218 bp
fragments confirmed that the desired in-frame deletion had been
obtained.
A second round of pyrE-based allele exchange was carried out in
the 630Derm and R20291 cwp84 mutants, using pMTL-
YN3::630cwp84c and pMTL-YN4::R20291cwp84c, respectively, to
restore the mutant alleles back to wild-type, in situ. A conservative
base substitution was made to introduce a ScaI restriction site into
the restored cwp84 sequence (Figure 5A). Three 630Derm FOA
resistant colonies were screened and yielded a 1.1 kb PCR product
with primers cwp84-F4 and cwp84-R4, indicating that the cwp84
allele had been successfully restored (Figure 5B). Subsequent
digestion of the PCR products with ScaI confirmed that
restoration of the cwp84 allele had been successful in each of the
three clones screened (Figure 5C). Similar analysis was carried out
on nine R20291 FOA resistant clones. Successful restoration of
cwp84 was confirmed in each of the nine clones, as evidenced by a
1.1 kb PCR product which was cleaved by Sca I (data not shown).
Before carrying out any phenotypic characterisation, the cwp84
mutants and their restored derivatives were converted back to a
pyrE-positive (uracil prototrophy) phenotype using pMTL-YN1
Figure 3. Segregational stability of pMTL83*251 or pMTL83251
in C. difficile strain 630Derm. The two plasmids differ only in that
pMTL83*251 has a frame shift in the pCB102 RepH gene, introduced by
blunt-end ligation following cleavage with NsiI. Cells carrying the two
plasmids were grown in BHIS media in the absence of antibiotic and
then CFUs estimated on agar media supplemented with thiamphenicol
after 6, 12 and 24 h of growth. The illustrated data was derived from
three independent experiments.
doi:10.1371/journal.pone.0056051.g003
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and pMTL-YN2 for the 630Derm-derived strains and the R20291-
derived strains, respectively. In keeping with previous observations
[21,22], the mutants grew poorly on anaerobic blood agar
compared to the wild-type and the complemented strains
(Supporting Information File S1). S-layer extracts from the WT,
mutant and complemented strains were prepared by the glycin
acid method. The absence of the Cwp84 protease in the 630Derm
and R20291 mutant strains was confirmed by immunoblot
analysis with anti-Cwp84 antibodies (Figure 6A). Furthermore,
while glycin extracts of both the 630Derm wild type strain and the
complemented mutant contained two bands corresponding to the
cleaved HMW and LMW S-layer proteins, only a band
corresponding to the unprocessed SlpA precursor was evident in
the cwp84 mutant strain (Figure 6B). Interestingly, whilst broadly
equivalent results were obtained with the R20291 strains, it was
clear that the cwp84 mutant contained two lower intensity bands,
most likely corresponding to the HMW and LMW, in addition to
the SplA precursor (Figure 6B). The identity of the HMW-SLP
band was further confirmed by immunoblot (Figure 6C). This
suggests that some proteolytic cleavage of SlpA may have occurred
in the R20219 mutant, despite the absence of Cwp84.
Creation and rapid in trans complementation of in-frame
deletion mutants
Whilst the in situ complementation of mutant alleles represents
the ‘gold standard’, the procedure required is lengthy (approx. 3–4
weeks), and therefore adds to the time needed to characterise a
mutant. An alternative strategy would be, having made a specific
in-frame deletion in a pyrE strain, to use ACE to introduce a wild
type copy of the gene into the chromosome at the pyrE locus
concomitant with the correction of this allele back to a PyrE-
positive phenotype. Accordingly, complementation vectors
(pMTL-YN1C and pMTLYN2C, for strains 630 and R20291,
respectively) were constructed (MATERIALS AND METHODS)
especially for this purpose, together with derivatives (pMTL-
YN1X and pMTLYN2X, for strains 630 and R20291, respec-
tively) carrying a strong promoter (the fdx promoter) to direct the
over expression of the complementing gene. In contrast to in situ
complementation, and as a consequence of being able to directly
select for uracil prototrophy without the need to isolate pure single
crossover clones, the successful introduction of genes using these
vectors takes between 5 and 7 days.
To test the utility of this approach, we targeted the mtlD gene
which forms part of the operon responsible for mannitol
metabolism in C. difficile strain 630Derm, using plasmid pMTL-
YN3::630mtlD. The ability of C. difficile to ferment mannitol is a
distinguishing feature and forms the basis of CDSA (Clostridium
difficile Selective Agar) developed by Becton Dickinson [23].
Fermentation of mannitol in this medium causes a pH drop, which
causes the indicator present to change in color, from red to yellow.
In many bacteria mannitol is transported into the cell via a typical
phosphotransferase system (PTS), and therefore couples transport
to phosphorylation of the sugar [24]. The mtl operon in E. coli
consists of the mtlA, mtlR, and mtlD genes that respectively encode
Figure 4. Allelic Exchange vectors for manipulation of C. difficile 630Derm (pMTL-YN3) and R20291 (pMTL-YN4). Common plasmid
components are: CatP, the catP gene of Clostridium perfringens conferring thiamphenicol resistance; PyrE, the pyrE gene of Clostridium sporogenes;
ColE1, the replication region of the E.coli plasmid ColE1, and; TraJ, transfer function of the RP4 oriT region; Z, the lacZ’ gene encoding the alpha
fragment of the E.coli b-galactosidase (and containing a multiple cloning site, MCS, region derived from plasmid pMTL20); T1, a transcriptional
terminator isolated from downstream of the Clostridium difficile strain 630 CD0164 gene, and; T2, a transcriptional terminator of the ferredoxin gene
of Clostridium pasteurianum. The position of the frame-shift generated at the NsiI site is indicated by an asterick. Plasmid pMTL-ME2 is identical to
plasmid pMTL-YN3, except it carries an NsiI site at the 39-end of RepH at the position marked by an asterick.
doi:10.1371/journal.pone.0056051.g004
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the mannitol transporter (enzyme IICBAmtl), a transcriptional
regulator, and mannitol-1-phosphate dehydrogenase [25]. The
arrangement of genes in C. difficile 630Derm is predicted to be
equivalent to that of B. stearothermophilus and comprises four
putative genes: mtlA (enzyme IICBmtl), mtlR, mtlF (enzyme IIAmtl),
and mtlD [26,27].
Following transfer of the knock-out plasmid pMTL-
YN3::630mtlD into C. difficile 630Derm, three FOA resistant clones
were isolated. PCR screening using primers mtlD-F3 and mtlD-
R3, that anneal to the upstream and the downstream sequence of
mtlD, demonstrated that two clones were DmtlDmutants, yielding a
PCR product of 1,418 bp, while the third clone was a wild type
revertant, yielding a PCR product of 2,582 bp (Supporting
Information File S1). Nucleotide sequencing of the 1,418 bp
products confirmed that the desired mtlD in-frame deletion had
been created.
On isolation of the mtlD mutant, the pyrE2 gene was converted
back to pyrE+ using plasmid pMTL-YN1 as described above. In
addition, two further derivatives of pMTL-YN1 were employed
which simultaneously delivered a functional copy of the mtlD wild
type gene into the genome immediately downstream of the
corrected pyrE gene. Plasmid pMTL-YN1CmtlD introduced the
mtlD structural gene into the chromosome together with its native
promoter. In contrast, pMTL-YN1XmtlD placed the inserted gene
under the control of the strong fdx promoter. In both instances, the
inserted mtlD gene was followed by the transcriptional terminator
sequence [6] derived from the ferredoxin gene of Clostridium
pasteurianum. The purpose of the terminator was to prevent polar
effects being exerted by the inserted gene on the downstream gene,
CD0188. In both cases, six independent PyrE+ clones able to grow
on minimal media in the absence of uracil were screened for the
presence of the wild type allele by PCR using primers Cdi630-
pyrD-sF1 and Cdi630-CD0189-SR3. All twelve clones gave the
expected 2,058 bp DNA product, equivalent to a wild type
control. Nucleotide sequencing confirmed its identity as a wild
type pyrE allele.
Phenotypic analysis confirmed that the mtlD mutant was no
longer able to ferment mannitol. Thus, in contrast to the wild type
Figure 5. PCR screening of double crossover candidate clones
for complementation of the cwp84 gene in C. difficile 630 Derm
Dcwp84. (A) Schematic diagram of the complementation of cwp84,
with a single nucleotide change to base 2280 of cwp84 from a T to an A,
without changing the corresponding valine amino acid residue and at
the same time creating a ScaI site. The purpose of this single nucleotide
change was to prove the occurrence of the complementation event. (B)
PCR screening of candidate clones of the complemented cwp84 gene.
Primers cwp84-F4 and cwp84-R4 anneal to the internal sequence of the
knockout cassette and the downstream sequence of cwp84, respec-
tively, resulting in a 1, 026 bp PCR product from double-crossover
complemented clones and wild-type, while no PCR product is expected
from Dcwp84 mutants. MW is a 2-Log DNA Ladder (NEB) molecular
weight marker, WT is a wild-type C. difficile DNA control, and 1–3 are the
candidate clones. All candidates 1 to 3 show the expected comple-
mented 1, 026 bp band, thereby confirmed as cwp84 complemented
clones, as seen in the wildtype control. (C) PCR products amplified using
primers cwp84-F4 and cwp84-R4 from candidates clones and wildtype
were analysed by RE digestion with ScaI. PCR products amplified from
cwp84 complemented clones were cut into two fragments (786 and
240 bp), whereas PCR products amplified from the wildtype control did
not.
doi:10.1371/journal.pone.0056051.g005
Figure 6. Glycin extracts analysis of 630Derm and R20291 WT,
mutant and complemented strains. (A) Immunoblot analysis with
anti-Cwp84 antibodies of glycin extracts, showing complete absence of
Cwp84 in the mutants compared to WT and complemented strains. (B)
SDS-PAGE of glycin extracts of 630Derm and R20291 WT, mutant and
complemented strains, showing no processing of SlpA precursor in the
630Dcwp84 mutant, and in contrast, an incomplete processing of SlpA
in the R20291Dcwp84 mutant. (C) Identification of the HMW-SLP in the
glycin extract of the R20291Dcwp84, showing that a partial processing
of SlpA takes place in this mutant even in absence of the Cwp84
protease. Lanes 1, 630Derm; lanes 2, 630DermDcwp84; lanes 3,
630DermDcwp84 complemented; lanes 4, R20291; lanes 5,
R20291DermDcwp84; lanes 6, R20291DermDcwp84 complemented;
MW, molecular weight standard.
doi:10.1371/journal.pone.0056051.g006
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and complemented strain, no growth was evident on minimal
media containing mannitol as the sole carbon source (Figure 7A).
Moreover, growth of the mutant in liquid media comprising a
mannitol-rich complex media (BD Diagnostics, USA) was severely
retarded (Figure 7B), and only a slight decrease in the pH of the
culture was evident (Figure 7C). The complemented mutant, on
the other hand grew at the same rate as the wild type, as did the
complemented mutant in which the native mtlD promoter had
been replaced with the strong fdx promoter. In this instance, at
least, any phenotypic benefit of increasing the expression of mtlD
could not be measured.
Finally, to confirm the utility of this approach to complemen-
tation, we created the complementation plasmids pMTL-YN1C-
spo0A and pMTL-YN2Cspo0A (MATERIALS AND METHODS)
and used them to insert a functional copy of the strain 630Derm
spo0A gene into the genomes of the spo0A mutants of strains
630Derm and R20291 concomitant with restoration of the pyrE
mutant allele back to wild type. The sporulation phenotypes of the
resultant strains were restored to that of the wildtype (Supporting
Information File S1).
Discussion
For many years the gene tools available to bring about specific,
directed modifications of C. difficile at the genetic level were scant
indeed. In the present study we have capitalised on the
development of ACE technology to devise and exemplify methods
for the generation and complementation of precise allelic
exchange mutants in the C. difficile genome based on the use of
various pyrE alleles. The use of genes involved in uracil
metabolism, such as pyrE and pyrF, as a negative-/counter-
selection marker has previously been demonstrated in a number of
different bacteria and yeast [10–15], where it is reliant on the
initial creation of a mutant defective in the chosen gene to act as
the host for mutant construction. The deployment of ACE
technology ensures this is a relatively simple and rapid undertak-
ing. More important, as demonstrated here, ACE may be used to
rapidly convert the host back to pyrE+, allowing the assessment of
the mutant phenotype in a ‘clean’, wild type background. Such an
undertaken has not generally been applied in other systems. Thus,
for instance, the mutants created in C. thermocellum [15] using the
organisms own pyrF gene as a counter-selection marker were
always analysed in the DpyrF strain in which they were created.
Similarly, a mutagenesis system developed in Bacillus subtilis, based
on the use of the upp gene [28], has been adapted for use in C.
acetobutylicum (P Soucaille, pers comm.) and is always undertaken,
and the resultant mutants made analysed in, a upp- background.
The use of a background defective in nucleoside metabolism can
complicate the assessment of the effect of the mutation under
analysis. This is particularly the case in the investigation of
pathogens and virulence, where mutants in nucleoside metabolism
are considered a form of disablement in their own right [29]. This
has considerable impact on studies designed to assess the effect of
mutation of other loci on virulence, particularly in vivo.
We have demonstrated the robustness and reliability of this pyrE
method of mutagenesis in both C. difficile 630 Derm and C. difficile
R20291, through the creation of in-frame deletion mutants in
spo0A, cwp84 and mtlD. We have re-affirmed the value of strategies
based on pseudo-suicide vectors, and in the case of 630Derm
improved the options available through the further disablement of
the pCB102 replicon used by the introduction of a frameshift in
the repH gene. This was found to facilitate the ease with which
single crossover integrants were isolated, which tend to emerge
after just two passages of transconjugants on selective media. This
Figure 7. Growth of C. difficile 630Derm strains with mannitol as
the sole carbon source. (A) Clock-wise from top-left, C. difficile
630Derm (1) 630DermDmtlD mutant (2), and 630DermDmtlD-comple-
mented (3) and 630DermDmtlD-overexpressed (4) were streaked onto
minimal media agar with mannitol as the sole carbon source and
incubated for 48 h to observe growth. In contrast to the wild type,
complemented and overexpressed strains, no growth was evident for
the 630DermD mtlD mutant. (B) The growth of DmtlD was limited in
mannitol broth, while growth of the DmtlD complemented and mtlD
overexpressed strains were restored to wildtype levels. (C) The pH of
the media broth showed a dip in pH caused by the fermentation of
mannitol for the wildtype, DmtlD complemented and DmtlD overex-
pressed strains, which correlate to their growth. The 630 Derm DmtlD
mutant strain grew very weakly in mannitol broth, which was reflected
in the sustained pH levels of the media. All experiments were
undertaken in triplicate. The data, complete with error bars is provided
in the Supporting Information File S1.
doi:10.1371/journal.pone.0056051.g007
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is in contrast to strain R20291 allelic exchange vectors, which
make use of the pBP1 vector. During the course of this work we
have confirmed that the annotated mtlD locus is indeed involved in
mannitol utilisation and re-affirmed that Cwp84 plays a role in the
processing of SlpA. Intriguingly, we found that despite the
introduction of the cwp84 frame-shift in R20291, unlike 630Derm,
some processing of SlpA was still occurring in this strain. The in-
frame deletion of both strains results in an internal deletion of 406
amino acids from the protein (total 804 amino acids). Whilst the
truncated protein that results still contains Cys116, an important
residue in the active site of the protease [22], it seems unlikely that
the protein retains proteolytic activity, particularly as the truncated
protein in the 630Derm mutant is identical. Moreover, no signal
was detected by immunoblot analysis in the two mutant strains,
suggesting that there is no expression at all of the protease, even in
a truncated form, or that this form is quickly degraded in the cell.
Perhaps strain R20291 produces a secondary protease also able to
process SlpA? At this stage no one explanation can be ruled out.
Here our focus has been on the development and description of
the mutagenesis method, and our data on individual mutants
remains observational.
The method developed here is in many respects equivalent to
our recent description of the use of codA as a counter selection [8].
Indeed, the allelic exchange cassettes and methodological proce-
dures are the same, except counter-selection is based on
differential resistance to FOA (PyrE) rather than FC (CodA).
Accordingly, the isolation of mutants using either protocol takes
around 3–4 weeks to accomplish once the allelic exchange vectors
have been constructed, and both methods may be subsequently
employed to undertake in situ complementation of the mutated
allele (exchange of the mutant allele with the wild type gene). A
pivotal difference is that codA-based mutagenesis [8] can be
undertaken in a wild type background (provided the host does not
carry a native codA gene, as is the case in C. botulinum, C. sporogenes
and C. ljungdahlii), whereas the method described here requires the
initial creation of a pyrE mutant which needs to be corrected back
to wild type once a mutant at a distal locus has been created.
However, using ACE, this is rapid (5 days), and provides the
opportunity to complement the mutant in parallel, through
concomitant insertion of a wild type copy of the gene either
under the control of its native promoter, or the strong fdx
promoter.
Complementation is essential to unequivocally confirm the role
of a genetic determinant in a specific phenotype [30]. Comple-
mentation is traditionally achieved using multicopy plasmids. The
consequent abnormal gene dosage can, however, frequently fail to
restore phenotype to wildtype levels. Thus, CwpV was over
produced in a plasmid complemented cwpV mutant of C. difficile
[31], the perfringolysin O titre of a virR mutant of the C. perfringens
strain 56 was approximately 3-fold higher than the wild type strain
when complemented with a multicopy plasmid carrying the virRS
genes [32], while in a study of Clostridium septicum ‘haemolytic
activity of the complemented strain was higher than the parent
strain ….. presumably a reflection of the presence of the csa gene
on a multicopy plasmid.’ [33]. In the study of Dingle and co-
workers [34], ‘although the wild-type 630Derm strain and the fliC
mutant strain produced FliD, the fliC-complemented strain did
not, suggesting that there was a reduction in fliD gene expression
when FliC is expressed in trans off a plasmid rather than in cis
from the chromosomal gene’. Similarly, plasmid complemented
agr mutants of Clostridium perfringens failed to completely regain wild-
type sporulation levels [35], a phenomenon attributed by the
authors to ‘complementation involving a multicopy plasmid
carrying the cloned agr locus’.
Ancillary effects can also arise when using plasmids for
complementation studies due to the need to maintain plasmids,
and the complementing gene, through supplementation with
antibiotics. Thus, for instance, complementation of the a sleC
mutation using a plasmid-located gene did not restore the
phenotype to wild type [20], but did restore germination to the
reduced level obtained in a vector only control. The presence of
the plasmid alone, and most likely the effect of the added
thiamphenicol needed to maintain the plasmid, detrimentally
effected spore germination. Consequently, the use of plasmid
complementation systems may require the inclusion of a vector
only control [20]. This is not required when using ACE-based
complementation at the pyrE locus. Crucially, the intrinsic stability
of chromosomal complementation makes it the method of choice
in those situations where plasmid maintenance through antibiotic
supplementation is not a viable option, such as when comple-
mentation in an in vivo model is required.
The use of plasmids pMTL-YN1C and pMTL-YN2C positions
the complementing gene in the genome immediately downstream
of the pyrE gene (CD0187). This allows read through from the
upstream promoter responsible for transcription of pyrE, the
identity of which is unknown but may reside immediately
upstream of CD0187 or, more likely, CD0184. The availability
of transcriptional read through is important in those cases where
the identity of the natural promoter of the complementation gene
is not defined, and cannot be guaranteed to be cloned along with
the structural gene, allowing, for instance, a promoter-less copy of
the structural gene to be cloned. In those instances where the
promoter is defined, and the operator wishes to exclude read
through, a transcriptional terminator may simply be added during
the cloning of the complementation gene and its promoter.
In certain instances it may be desirable to bring about
‘overexpression’ of the complementing gene. For this purpose,
two further vectors were constructed (pMTL-YN1X and
pMTLYN2X, for strains 630 and R20291, respectively) carrying
the promoter of the ferredoxin gene (fdx) of Clostridium sporogenes. As
a consequence of its central role in anaerobic electron transfer, the
ferredoxin gene is highly expressed in Clostridium, with the
ferredoxin protein representing, for instance, up to 2% of the
soluble protein in Clostridium pasteurianum [36]. Indeed the fdx
promoter of C. perfringens has been used to derive a highly effective
clostridial expression system [37], while the C. sporogenes fdx
promoter used here was employed to maximise expression of a
nitroreductase gene in C. sporogenes [38].
Whichever vectors are used, their deployment involves only
marginal additional effort compared to the use of autonomous
complementation vectors. Thus, both methods (plasmid-based and
ACE-based complementation) involve the assembly of the
requisite vector in E. coli and its transformation into the
appropriate clostridial mutant and the selection of transconjugants
on antibiotic supplemented plates. ACE-mediated complementa-
tion merely requires re-streaking of the primary transconjugant
onto minimal media lacking uracil. All those colonies that develop
represent complemented strains in which the pyrE allele has been
corrected to wildtype. The additional time required, therefore,
equates to merely the 2 days needed for uracil prototrophic
colonies to develop on the minimal media.
Conclusion
We have demonstrated the use of a pyrE-based allele exchange
system to make precise alterations to the genome of C. difficile. In
using a pyrE- strain as the host, by whatever means a mutant is
made (e.g., allelic exchange or ClosTron), the facility to insert a
wild type copy of the gene at the pyrE locus provides a rapid
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mechanism for generating a stable complementation clone that is
not compromised by inappropriate gene dosage effects. As such,
the pyrE mutants made here are available to the scientific
community for mutagenesis studies, along with the requisite pyrE
correction vectors. The genomes of both strains have been
subjected to genome re-sequencing and found to be devoid of any
additional SNPs or Indels compared to the progenitor 630Derm
strain or R20291 parental strains.
Materials and Methods
Bacterial strains and growth conditions
Escherichia coli TOP10 (Invitrogen) and E. coli CA434 [39] were
cultured in Luria-Bertani (LB) medium, supplemented with
chloramphenicol (25 mg/ml), where appropriate. Routine cultures
of C. difficile 630 Derm [40] and C. difficile R20291 were carried out
in BHIS medium (brain heart infusion medium supplemented with
5 mg/ml yeast extract and 0.1% [wt/vol] L-cysteine) [41]. C.
difficile medium was supplemented with D-cycloserine (250 mg/ml),
cefoxitin (8 mg/ml), lincomycin (20 mg/ml), and/or thiamphenicol
(15 mg/ml) where appropriate. A defined minimal media [18] was
used as uracil-free medium when performing genetic selections. A
basic nutritive mannitol broth for growth assays of C. difficile strains
were prepared as follows : Proteose peptone no. 2 4% [wt/vol]
(BD Diagnostics, USA), sodium phosphate dibasic 0.5%[wt/vol],
potassium phosphate monobasic 0.1%[wt/vol], sodium chloride,
0.2% [wt/vol], magnesium sulfate, 0.01% [wt/vol], mannitol,
0.6% [wt/vol] with final pH at +/27.35. For solid medium, agar
was added to a final concentration of 1.0% (wt/vol). Clostridium
sporogenes ATCC 15579 was cultivated in TYG media [7]. All
Clostridium cultures were incubated in an anaerobic workstation at
37uC (Don Whitley, Yorkshire, United Kingdom). Uracil was
added at 5 mg/ml, and 5-Fluoroorotic acid (5-FOA) at 2 mg/ml.
All reagents, unless noted, were purchased from Sigma-Aldrich.
Conjugation into C. difficile
Plasmids were transformed into E. coli donor, CA434 and then
conjugated into C. difficile [42]. Thiamphenicol (15 mg/ml) was
used to select for catP-based plasmid. D-cycloserine (250 mg/ml)
and cefoxitin (8 mg/ml) were used to counter select against E. coli
CA434 after conjugation.
DNA manipulations
DNA manipulations were carried out according to standard
techniques. C. difficile genomic DNA for use in cloning and PCR
analysis was prepared as described previously [9]. Polymerase
chain reactions (PCR) used FailsafeTM PCR system (Epicentre)
and Taq polymerase (Promega) in accordance with the manufac-
turers’ protocols using primers detailed in Table 1. Primer design
for amplification of DNA from C. difficile 630 Derm and R20291
strains were based on the available C. difficile genomes from the
EMBL/GenBank databases with accession numbers AM180356
and FN545816 respectively. The oligonucleotides and the
plasmids/strains used in this study are listed in Table 1 and
Table 2, respectively. All DNA manipulations and cloning
procedures were performed as per Sambrook [43].
Vector Construction
Plasmid pMTL-YN18 (accession number; JX465728), used to
create a pyrE2 mutant in R20291, is an equivalent vector to
pMTL-JH18 [9] in which the pCB102 replicon was replaced with
that of pBP1 (isolated from pMTL82251), using the flanking AscI
and FseI sites specifically created for this purpose [17]. Plasmid
pMTL-YN1 (accession number; JX465729) was made by cloning
a 1,753 bp SbfI/AscI fragment between the corresponding
restriction sites of plasmid pMTL-JH20 [9]. This fragment was
generated from the 630Derm genome by PCR using the primers
pyrE-int-SbfI-F and pyrEcomplement-Asc1-R, and carries a
truncated copy of pyrE, lacking the first 50 nucleotides of the
structural gene, together with 1200 bp from immediately 39 to the
stop codon of pyrE, which includes the entire coding sequence of
CD0188 of 630Derm. To generate the equivalent pyrE correction
vector (pMTL-YN2, accession number; JX465732) for R20291,
the pCB102 replicon of pMTL-YN1 was replaced with that of
pBP1 from pMTL82251 (using the AscI and FseI sites) and the
630Derm DNA between the SbfI and AscI sites replaced with the
equivalent region from the R20291 genome. In this case, the DNA
was synthesized by DNA2.0 specific to the R20291 chromosome
by PCR as two contiguous SbfI/NdeI and NdeI/AscI fragments.
The PyrE complementation vector pMTL-ME2 was constructed
by inserting the C. sporogenes ATCC 15579 pyrE gene into
pMTL83151. The pyrE gene was amplified by PCR from genomic
DNA prepared from Clostridium sporogenes ATCC 15579 using
primers Csp-pyrE-HpaI-sF1 and Csp-pyrE-HpaI-sR1. The PCR
product was digested with HpaI and gel purified followed by
cloning in same orientation as catP in pMTL83151 [17] linearized
with the same enzyme.
To construct the ACE overexpression plasmids pMTL-YN1X
(accession number; JX465731) and pMTL-YN2X (accession
number; JX465734), a 214 bp NotI/NdeI fragment encompassing
the C. sporogenes fdx promoter was isolated from plasmid
pMTL82253 and inserted between the equivalent sites of
pMTL-JH14 [9]. The plasmid obtained (pMTL-JH14::Pcspfdx)
was cleaved with NheI, and ligated to two, annealed oligonucle-
otides (Cpa-TT-Oligo-1 and Cpa-TT-Oligo-2) which encom-
passed the transcriptional terminator of the Clostridium pasteurianum
ferredoxin gene. A 517 bp NotI/NheI fragment (encompassing
the fdx promoter, lacZ’ and multiple cloning sites, and the
transcriptional terminator of the C. pasteurianum ferredoxin gene)
was then isolated from the resultant plasmid (pMTL-ME6X) and
inserted between the equivalent sites in pMTL-YN1 and
pMTLYN2, to yield pMTL-YN1X and pMTL-YN2X, respec-
tively. In parallel, pMTL-ME6X was digested with EcoRI and
NheI and the released 293 bp fragment inserted between the
equivalent sites of pMTL-JH14 [9] to make pMTL-ME6C. This
plasmid was then cleaved with NotI and NheI, and the released
323 bp fragment inserted between the equivalent sites of pMTL-
YN1 and pMTLYN2, to yield the complementation vectors
pMTL-YN1C (accession number; JX465730) and pMTL-YN2C
(accession number; JX465733), respectively.
Allelic Exchange Cassettes
Allele exchange cassettes were assembled, specific to the three
target loci (spo0A, cwp84 and mtlD) of the two strains, composed of
a left-hand homology arm (LHA) and a right-hand homology arm
(RHA), each of approximately 500 to 800 bp in size. Each cassette
was cloned between the SbfI and AscI restriction recognition sites in
pMTL-YN3 (accession number; JX465735) to create pMTL-
YN3::630spo0A*, pMTL-YN3::630cwp84* and pMTL-
YN3::630mtlD*. Similarly, pMTL-YN3::R20291spo0A* and
pMTL-YN3::R20291cwp84* were made by cloning the allelic
exchange cassettes between the AscI and SbfI sites in pMTL-YN4
(accession number; JX465736).
The spo0A knockout cassette was synthesized by DNA2.0 which
consists of a 672 bp LHA (bases 1412012 to 1412789 on the
forward strand of C. difficile 630 Derm genome) fused to a 800 bp
RHA (bases 1413275 to 1414074 on the forward strand of C.
difficile 630 Derm genome) which were designed to make an in-
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frame deletion removing codons 65 to 226, inclusive, out of a total
of 275 codons). For the equivalent in C. difficile R20291, a 778 bp
LHA (bases 1319650 to 1320427 on the forward strand of the C.
difficile R20291 genome) was fused to a 800 bp RHA (bases
1320913 to 1321712 on the forward strand of the C. difficile
R20291 genome). Each cassette was designed to incorporate a SbfI
site at the 59 end and an AscI site at the 39 end to facilitate cloning
into the pMTL-YN3 plasmid. The cwp84 knockout cassette
consists of a 653 bp LHA (bases 1045907 to 1046559 on the
reverse strand of the C. difficile 630 Derm genome) fused to a 558 bp
RHA (bases 1047778 to 1048335 on the reverse strand of the C.
difficile 630 Derm genome) which were designed to remove codons
214 to 629, inclusive, representing the removal of 417 codons from
a total of 814). For the equivalent in C. difficile R20291, a 713 bp
LHA (bases 1067119 to 1067771 on the reverse strand of the C.
difficile R20291 genome) was fused to a 558 bp RHA (bases
1068990 to 1069547 on the reverse strand of the C. difficile R20291
genome). The mtlD knockout cassette consists of a 654 bp LHA
(bases 1593564 to 1594217 on the reverse strand of the C. difficile
630 Derm genome) fused to a 654 bp RHA (bases 1595353 to
1596006 on the reverse strand of the C. difficile 630 Derm genome)
which were designed to make an in-frame deletion between codon
3 and codon 387 of mtlD (total codons 388).
Complementation Vectors
Plasmids for the complementation of the spo0A mutants of
strains R20291 and 630Derm were constructed as follows. The
spo0A of strain C. difficile 630Derm was PCR amplified as a 1216 bp
DNA fragment using the two primers spo0A-SpeI-F and spo0A-
BamHI-R and cloned in pCR2.1 vector (Invitrogen) and verified
by sequencing. The spo0A was re-isolated as a 1.2 kb EcoRI and
BamHI fragment and inserted between the equivalent sites of
pMTL-YN2C to give the R20291 complementation plasmid
pMTL-YN2Cspo0A. To derive an equivalent plasmid for strain
630Derm, the spo0A gene was excised from pMTL-YN2Cspo0A as a
1.2 kb DNA fragment following cleaved with NotI and BamHI
and inserted into the appropriate sites of pMTL-YN1C to give the
complementation plasmid pMTL-YN1Cspo0A.
To generate the two required allelic exchange cassettes need for
complementation of the cwp84 in-frame deletions, the portion of
cwp84 missing in the two plasmids (pMTL-YN4::R20291cwp84*
and pMTL-YN3::630cwp84*) originally used to make the in-frame
deletions were synthesised (DNA2.0) as a 1,082 bp NdeI-KpnI
fragment (R20291) and a 1,255 bp NdeI-XbaI fragment (630Derm)
generated by cloned into the appropriate allelic exchange vectors
to yield plasmids pMTL-YN4::R20291cwp84c and pMTL-
YN3::630cwp84c. In order to be able to distinguish the comple-
mentation allele from wild type, the synthesised region included a
single nucleotide change (T to A) to base 2280 of cwp84 which
retains the codon specificity (codon 760, Valine) but creates a ScaI
restriction enzyme recognition site.
The complementation plasmid pMTL-YN1CmtlD was con-
structed by the PCR amplification of the C. difficile 630Derm mtlD
gene, together with its 59 non-coding region, as a 1,779 bp
Table 1. List of oligonucleotides used in this study.
Oligonucleotide Binding site Sequence (59 to 39)
Csp-pyrE-HpaI-sF1 pyrE of C.sporogenes AATATTGTTAACTAAGGAGAAGATATAAATGAGTAATATAAAT
GTTATAGATATATTAAAAGAATCAAAT
Csp-pyrE-HpaI-sR1 pyrE of C.sporogenes AATATGTTAACTTATTTTTGTTCTCTACTACCTGGTTTTACAAAAGGT
Cdi630-pyrD-sF1 pyrD of C. difficile AGAGAAGGAATAAAAAGTTTAGACGAAATAAGAGG
l6.5-sF2 6.5 kbp HindIII fragment of phage lambda,
insert-specific reverse primer
TATGAGTACCCTGTTTTTTCTCATGTTCAGG
Cdi630-CD0189-sR3 CD0189 of C. difficile,chromosome-specific reverse primer CCAAGCTCTATGACAGACAGCTCATTGTTTAGAAC
pyrE-int-SbfI-F pyrE of C. difficile 630 Derm and R20291 CTGCAGGGGAGGGACATTTTTTATTATCTTCAGG
pyrEcomplement-Asc1-R CD0188 of C. difficile 630 Derm and R20291 GGCGCGCCATAGTATATAACATTAATAAAATTTAAAATC
spo0A-YN-F2 upstream of spo0A of C. difficile GGCAAGTATAAACTTGGATTATGGGTAAGAGAT
spo0A-YN-R2 downstream of spo0A of C. difficile CTATATATCTTTCCATCTACAACTTCTATAG
cwp84-F3 upstream of cwp84 of C. difficile TTCTATAATTAATATGTACTCATAATCC
Cwp84-F4 knockout region of cwp84 CTGGACAAGCTACTTCAGGAG
Cwp84-R4 downstream of cwp84 of C. difficile CTGGACAAGCTACTTCAGGAG
mtlD-F3 upstream of mtlD of C. difficile CTAGAGAATAGAATCGTGCTAGATTCAAATGAAG
mtlD-R3 downstream of mtlD of C. difficile CTTTAACTGAATACTCTCTTGCCTTAG
mtlD-NotI-F upstream of mtlD, inclusive of RBS and promoter sequence GCGGCCGCTTTTTAATCACTCCTTATATTTTTATAC
mtlD-BamHI-R end of coding sequence of mtlD GGATCCTTATAAATTTTTCATAAATATATAACTTTTTTCGATAT
TATTTAAAAGTTCTTCG
mtlD-NdeI-F start of mtlD coding sequence CATATGAAAAAGGCAATTCAGTTTGGAGCAGG
Cpa-TT-Oligo-1 transcriptional terminator of the Clostridium pasteurianum
ferredoxin gene
CTAGTATAAAAATAAGAAGCCTGCATTTGCAGGCTTCTTATTTTTATG
Cpa-TT-Oligo-2 transcriptional terminator of the Clostridium pasteurianum
ferredoxin gene
CTAGCATAAAAATAAGAAGCCTGCAAATGCAGGCTTCTTATTTTTATA
spo0A-SpeI-F spo0A gene of C. difficile ATATACTAGTGGTATTTTTATAGATGAAATGATAAAATTGTAG
spo0A-BamHI-R spo0A gene of C. difficile ATATGGATCCTCAGTTTACAACTTGTAAAGACAC
doi:10.1371/journal.pone.0056051.t001
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Table 2. List of strains and plasmids used in this study.
Strains/Plasmids Relevant features Source
E. coli Top10 mcrA D(mrr-hsdRMS-mcrBC) recA1 Invitrogen
E. coli CA434 hsd20(rB-, mB-, recA13, rpsL20, leu, proA2, with IncPb conjugative plasmid R702 [31]
C. difficile 630Derm Erythromycin sensitive strain of strain 630 [34]
CRG1496 C. difficile 630Derm DpyrE This study
CRG2547 Derived from CRG1496, in-frame deletion within spo0A, pyrE repaired to wildtype sequence This study
CRG2302 Derived from CRG1496, in-frame deletion within cwp84, pyrE repaired to wildtype sequence This study
CRG2445 Derived from CRG2302, in situ complementation of Dcwp84 with a single nucleotide
change, pyrE repaired to wildtype sequence
This study
CRG2923 Derived from CRG1496, in-frame deletion within mtlD, pyrE repaired to wildtype sequence This study
CRG2536 C. difficile 630_erm mtlD::intron ermB This study
CRG2926 Derived from CRG2923, chromosomal complementation of mtlD with its natural RBS
and promoter region, downstream of pyrE
This study
CRG2929 Derived from CRG2923, chromosomal complementation of mtlD preceded by the promoter
region (Pfdx) of the Clostridium sporogenes ferredoxin gene, downstream of pyrE
This study
C. difficile R20291 wild-type BI/NAP1/027 Stoke Mandeville (2004–2005) isolate Anaerobe Reference Laboratory,
Cardiff, Wales, United Kingdom
CRG2359 C. difficile R20291 DpyrE This study
CRG2548 Derived from CRG2359, in-frame deletion within spo0A, pyrE repaired to wildtype sequence This study
CRG2549 Derived from CRG2359, in-frame deletion within cwp84, pyrE repaired to wildtype sequence This study
CRG3059 Derived from CRG2549, in situ complementation of Dcwp84 with a single nucleotide
change, pyrE repaired to wildtype sequence
This study
pMTL-YN18 same as pMTLJH18::l6.5, but without the l6.5 fragment, homology arms are specific to
R20291 sequence and pCB102 replicon replaced with pBP1
This study
pMTL-ME2 Derived from pMTL83151 through addition of a C. sporogenes pyrE and C. perfringens catP
gene. Carries an unaltered pCB102 replicon, which includes a NsiI site in the repH gene.
This study
pMTL-YN3 Derived from pMTL-ME2 by blunt-end ligation of the NsiI site within repH, causing a
frame-shift in RepH
This study
pMTL-YN3::630spo0A* Same as pMTL-YN3, spo0A KO cassette cloned into SbfI/AscI sites This study
pMTL-YN3::630cwp84* Same as pMTL-YN3, cwp84 KO cassette cloned into SbfI/AscI sites This study
pMTL-YN3::630cwp84c Same as pMTL-YN3, full sequence of cwp84 with single base change cloned into SbfI/AscI sites This study
pMTL-YN4 Derived from pMTL-YN3 by replacing the pCB102 replicon with that of pBP1 This study
pMTL-YN4::R20291spo0A* Same as pMTL-YN4, spo0A KO cassette cloned into SbfI/AscI sites This study
pMTL-YN4::R20291cwp84* Same as pMTL-YN4, cwp84 KO cassette cloned into SbfI/AscI sites This study
pMTL-YN4::R20291cwp84c Same as pMTL-YN4, full sequence of cwp84 with single base change cloned into SbfI/AscI sites This study
pMTL-YN3::630mtlD* Same as pMTL-YN3, mtlD KO cassette cloned into SbfI/AscI sites This study
pMTL-YN1 same backbone as JH-18 but without the 6.5kb fragment of lphage DNA, entire pyrE coding
sequence minus the first 50 bases
This study
pMTL-YN1C same as pMTL-YN1, except for a MCS inserted after pyrE gene to enable cloning of target
gene for purpose of complementation
This study
pMTL-YN1C::mtlD same as pMTL-YN1C, with the full coding sequence of mtlD and its natural RBS cloned into
the NdeI and BamHI sites
This study
pMTL-YN1X same as pMTL-YN1C, for a fdx promoter inserted after pyrE gene and before the MCS to
enable overexpression of target gene
This study
pMTL-YN1X::mtlD same as pMTL-YN1C::mtlD, with the full coding sequence of mtlD cloned downstream
of the fdx promoter into the NdeI and BamHI sites
This study
pMTL-YN2 same as pMTL-YN1, but with homology arms specific to R20291 sequence and pCB102
replicon replaced with pBP1
This study
pMTL-YN2C same as pMTL-YN1C, but with homology arms specific to R20291 sequence and pCB102
replicon replaced with pBP1
This study
pMTL-YN2X same as pMTL-YN1X, but with homology arms specific to R20291 sequence and pCB102
replicon replaced with pBP2
This study
doi:10.1371/journal.pone.0056051.t002
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fragment (using primers mtlD-NotI-F and mtlD-BamHI-R), and
its subsequent insertion, following cleaved with NotI and BamHI,
between the NotI and BamHI sites of pMTL-YN1C. pMTL-
YN1XmtlD was derived by the PCR amplification of the C. difficile
630Derm mtlD structural gene alone (ie., lacking its native
promoter), as a 1,161 bp fragment (using primers mtlD-NdeI-F
and mtlD-BamHI-R), cleaved with NdeI and BamHI, and
insertion between the NdeI and BamHI sites of pMTL-YN1X.
This positioned the mtlD gene under the transcriptional and
translational (RBS) control of fdx promoter.
ACE Procedure
The procedure adopted was as previously described [9]. For
inactivation of pyrE, E. coli CA434 donor cells carrying pMTL-
YN18 were conjugated with R20291 and transconjugants selected
on BHIS media supplemented D-cycloserine (250 mg/ml), cefox-
itin (8 mg/ml), thiamphenicol (15 mg/ml) and uracil (5 mg/ml). A
single transconjugant was re-streaked onto the same medium and
then a ‘large’ representative colony streaked onto minimal agar
medium agar supplemented with FOA (2 mg/ml) and uracil
(5 mg/ml). The colonies that arose were re-streaked twice onto the
same media, and analyzed by PCR to confirm deletion of pyrE (as
detailed in Results), and Sanger sequencing was used to confirm
the expected genotype. Confirmation that the plasmid had been
lost, was obtained by patch plating onto BHIS agar supplemented
with thiamphenicol and establishing that no growth occurred. For
correction of the pyrE mutation (ie., plasmids pMTL-YN1, 1C,
1X, 2, 2C and 2X) transconjugants were streaked onto minimal
media without uracil or FOA supplementation and those colonies
that developed analysed as above.
Allelic exchange procedure
The adopted protocol resembles that used for the isolation of
allelic exchange mutants using codA as a negative selection marker
[8], except counter-selection was based on differential resistance to
FOA rather than FC. It in essence involves the initial isolation of
pure single crossovers clones, and their subsequent transfer onto
selective plates to identify those cells in which the plasmid has
excised. These clones correspond to colonies that are resistant to
FOA as a consequence of loss of the heterologous PyrE+ allele and
reversion to a pyrE minus phenotype. Depending which homology
arm undergoes recombination, plasmid excision can result in
either the desired double crossover mutant, or a wild type cell. In
the absence of any bias, the wild type cells and desired mutants
should be present in equal proportions, ie., 50:50.
Each plasmid was conjugated into the appropriate host and
plated onto BHIS media (supplemented with cycloserine, cefox-
otin, thiamphenicol and uracil) and the transconjugants restreaked
onto fresh media to allow the identification of putative single
crossover mutants. These were readily identified as visibly larger
colonies after 16–24 hr. Such colonies were sequentially restreaked
from single colonies and after 2–4 passages, their identify and
purity confirmed by an appropriate PCR. Unlike ACE, where
powerful selection allows the purification of the desired double
crossover excision event, it is crucial that the single cross-over
integrants are pure, and not contaminated with wild type cells, ie.,
cells in which integration has not occurred. Otherwise, the
contaminating wild type cells, which are all resistant to FOA, will
cause unacceptable high background when cells are plated on
FOA media during the screen for the desired double crossover
events. To establish that no wild type cells were present, an
appropriate primer pair (spo0A-YN-F2/spo0A-YN-R2 in the case
of spo0A, cwp84-F3/cwp84-R4 in the case of cwp84, and mtlD-F3/
mtlD-R3 the case of mtlD) was used that annealed to the
chromosome at positions that flanked the site of the in-frame
deletion but that were both distal to the regions that comprised the
homology arms of the plasmid borne allelic exchange cassette. The
absence of a DNA product of a size consistent with the wild type
indicated clonal purity, and that wild type cells were not present.
To confirm that they were indeed single crossover integrants, two
different primers (M13F and M13R) were used that annealed to
plasmid specific sequences together with the appropriate flanking
primers. The presence of a DNA fragment indicated that the
clones were indeed single crossover integrants, while the size was
diagnostic of at which homology arm (LHA or RHA) recombi-
nation had occurred.
Following the isolation of pure single crossover integrants of the
two strains, a single colony was re-streaked onto minimal medium
supplemented with FOA and uracil to select for cells in which the
integrated plasmid had excised. The isolated FOA resistant
colonies were then screened by PCR using primers that anneal
to the upstream and the downstream sequence of the respective
target. DNA products of the predicted size were subjected to
Sanger sequencing to confirm their genotype.
Cwp84 Analysis Methods
S-layer extracts from the WT, mutant and complemented
strains were prepared by the glycin acid method [44]. Proteins
were separated by SDS-PAGE and transferred onto a PVDF
membrane for immunoblotting. Blocking of the membrane was
followed by incubation with either anti-Cwp84 (1/2,000 dilution)
or anti-HMW-SLP (1/10,000 dilution). Washing was done as
previously described [45], and bound antibodies were detected
using goat anti-rabbit immunoglobulin G alkaline phosphatase
conjugate (1/20,000 dilution; Sigma) with the substrates nitroblue
tetrazolium and 5-bromo-4-chloro-3-indolylphosphate (Sigma).
Anti-HMW-SLP antibodies were a kind gift from Pr. Neil
Fairweather, Imperial College, London.
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